Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, MS 38677, United States.
Catalent Pharma Solutions, 14 School House Road, Somerset, NJ 08873, USA.
Int J Pharm. 2019 Jan 30;555:380-393. doi: 10.1016/j.ijpharm.2018.11.045. Epub 2018 Nov 17.
Dry granulation is the preferred technique for solvent-sensitive products, especially drugs with stability problems such as hydrolysis. Twin-screw granulation is a continuous granulation technique, offering a potential alternative to conventional dry granulation techniques such as roller compaction. The major advantage of twin-screw granulation is the ability to adjust process parameters of dry granulation without compromising the compression properties. This study was aimed to perform exploratory studies of heat-assisted continuous twin-screw dry granulation process to formulate sustained release tablets for APIs with different melting points: theophylline, acetaminophen and lidocaine hydrochloride hydrate. Granulation feasibility was studied with different binders (e.g. Klucel™ EF, Kollidon® VA64), sustained release agents (e.g. Klucel™ MF, Eudragit® RSPO) and diluents at various drug loads. The processing conditions were below the melting point or glass transition temperature of the formulation ingredients. After successful granulation, DSC and XRD studies revealed the crystalline nature of the granules and FTIR studies showed no interaction of the API with the excipients. The granules were compressed into sustained release tablets without any compressibility issues. The tablets were stable after testing for 6 months at 25 °C/60% RH. This novel continuous dry granulation technique may offer an excellent alternative to conventional dry granulation techniques.
干法造粒是对溶剂敏感产品的首选技术,特别是对那些有水解等稳定性问题的药物。双螺杆造粒是一种连续造粒技术,为传统的干法造粒技术(如滚压)提供了潜在的替代方法。双螺杆造粒的主要优势在于能够调整干法造粒的工艺参数,而不会影响压缩性能。本研究旨在对热辅助连续双螺杆干法造粒工艺进行探索性研究,为具有不同熔点的 API (如茶碱、对乙酰氨基酚和盐酸利多卡因水合物)制备缓控释片。使用不同的粘合剂(如 Klucel™ EF、Kollidon® VA64)、缓控释剂(如 Klucel™ MF、Eudragit® RSPO)和稀释剂在不同的药物载量下研究了造粒的可行性。加工条件低于配方成分的熔点或玻璃化转变温度。成功造粒后,DSC 和 XRD 研究表明颗粒具有结晶性质,FTIR 研究表明 API 与赋形剂之间没有相互作用。将颗粒压制成缓控释片,没有任何可压缩性问题。这些片剂在 25°C/60%RH 条件下测试 6 个月后稳定。这种新颖的连续干法造粒技术可能为传统的干法造粒技术提供了一个极好的替代方案。